Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Levagen+® Palmitoylethanolamide (PEA) Supplementation on Parameters of Stress, Wellbeing and Cognition in University Students

NCT06225440 is registered in ClinicalTrials.gov with University of Westminster as lead sponsor.

NCT NCT06225440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06225440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Levagen+® Palmitoylethanolamide (PEA) Supplementation on Parameters of Stress, Wellbeing and Cognition in University Students
Lead sponsor
University of Westminster
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
January 31, 2024
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

well-being, psychological, wellness, psychological